Concepedia

Publication | Open Access

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

26

Citations

30

References

2021

Year

Abstract

NCT03029598.

References

YearCitations

Page 1